Background: Therapeutic inertia (TI) remains a critical barrier to optimizing outcomes in multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSDs).
Objective: We evaluated the proficiency of ChatGPT-4o in addressing complex neuro-immunological management challenges compared to practicing neurologists.